You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -8.1% | 36.4% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -488.2 | 0.0 |
| PEG | 0.0 | -0.1 |
| Price / Revenue | 50.4 | 0.9 |
| Price / Book value | 0.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -99.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 13.72 | -2.08 | €-0.06 | -6.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 11.47 | -3.43 | -8.00p | -1.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 277.20 | 165.17 | 194.00p | 4.4 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 95.78 | -9.83 | -0.14p | -2,614.3 | 0.0 | n/a | n/a | 0.0% |
| UK regulator approves Novacyt Covid-19 test Sharecast News | 06 Dec |
|---|---|
| Novacyt's exsig Covid-19 PCR test receives UK approval Sharecast News | 15 Jul |
| Novacyt gets another Covid-19 test approved in the UK Sharecast News | 17 Feb |
| Liquidity Agreement and Total Voting Rights | 01-Feb-23 22:55 |
|---|---|
| DHSC Claim update – Trial date listed | 30-Jan-23 14:19 |
| Full Year 2022 Trading Update | 26-Jan-23 14:20 |
| Holdings in Company | 06-Jan-23 20:33 |
| Liquidity Agreement and Total Voting Rights | 03-Jan-23 21:45 |